Clinical Research

Study for Chronic Rhinosinusitis with Nasal Polyps

A clinical research study called ANCHOR is in need of volunteers to evaluate the efficacy and safety of an investigational medicine to treat nasal polyps.

Nasal polyps, also called nasal polyposis, are noncancerous growths on the lining of the nasal passages or sinuses. These growths result from chronic inflammation and are associated with asthma, recurring infection, allergies, drug sensitivity or certain immune disorders. Although small nasal polyps may not cause symptoms, larger growths can block nasal passages or lead to breathing problems, a lost sense of smell and infection.

A clinical research study called ANCHOR is in need of volunteers to evaluate the efficacy and safety of an investigational medicine to treat nasal polyps. Qualified participants may receive study-related supplies, medications and examinations at no cost, as well as compensation up to $100 per visit and additional travel support.

We have partnered with Midwest Immunology in Plymouth, MN to support this clinical trial and offer participation to our patients. Midwest Immunology has a dedicated research department, including physicians, certified nurse coordinators, nurse practitioners, and pharmacists. They collaborate with pharmaceutical companies and local specialists to offer new treatment opportunities and aide in the understanding of various illnesses and treatment options related to the immune system through clinical trials.

Who can take part in the study? 

You may be able to participate if: 

  • You are 18 years of age and older 
  • You have a history of nasal polyps
  • You are currently on daily treatment with INCS for at least 8 weeks prior to screening

Interested in taking part in this clinical trial?

Call Midwest Immunology’s Clinical Research Nurse, Teresa Wessels, or fill out the contact form below and we will contact you shortly.